Vaccinia Virus Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-05-06
Clinical Trial Update: Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years [Phase 2, Phase 3]
Phase 2/3 trial evaluating immunogenicity, reactogenicity, and safety of the VACΔ6 vaccine in adults 18-60; study completed.